Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Adenocarcinoma 1Advanced Gastrointestinal Malignancies 1Adenocarcinoma of the Stomach 1

Interventions

Cyclophosphamide 910Carboplatin 787pembrolizumab 746Paclitaxel 744Bevacizumab 716Cisplatin 708Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 338Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × indusatumab × Clear all
NCT02202759 2017-05-15

A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction

Takeda

Phase 2 Terminated
38 enrolled 23 charts
Gastrointestinal

Adenocarcinoma of the Stomach

NCT02202785 2017-05-15

A Study of MLN0264 in Patients With Pancreatic Cancer

Takeda

Phase 2 Terminated
43 enrolled 22 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT01577758 2016-09-07

Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C

Takeda

Phase 1 Completed
41 enrolled 18 charts
Gastrointestinal

Advanced Gastrointestinal Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡